Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and Russia
Version 2 2021-03-15, 14:04
Version 1 2021-01-29, 10:34
media
posted on 2021-03-15, 14:04 authored by Adis journals on behalf of, Gordon Cook, Alessandro Corso, Matthew Streetly, Larisa P. Mendeleeva, Vadim V. Ptushkin, Edmond Chan, Jon Ukropec, Wafae Iraqi, Assem Al-Akabawi, Huiling Pei, Maren Gaudig, Maria Teresa Petrucci, Adrian Alegre, Maria-Victoria MateosArticle full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
